97224 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
Sub-classes:FCRN/HSA BINDING MOLECULES AND METHODS OF USE
#2FCRN/ANTIGEN-BINDING MOLECULES AND METHODS OF USE
#3GENETICALLY ENGINEERED B CELLS AND METHODS OF USE THEREOF
#4ANTIGEN BINDING MOLECULES AND METHODS OF USE THEREOF
#5ANTIBODIES SPECIFICALLY BINDING PD-1, TIM-3 OR PD-1 AND TIM-3 AND THEIR USES
#6ANTI-BCMA CAR ANTIBODIES, CONJUGATES, AND METHODS OF USE
#7FCRN/HSA BINDING MOLECULES AND METHODS OF USE
#8FC POLYPEPTIDE HAVING ALTERED GLYCOSYLATION MODIFICATION
#9SPYCATCHER ANALOGS AND USES THEREOF
#10ANTIBODIES AGAINST PD-L1
#11METHODS OF TREATING NEOPLASTIC ASTROCYTOMA
#12TREATMENT OF NECROTIZING ENTEROCOLITIS WITH SEMISYNTHETIC POLYCLONAL HUMAN SECRETORY IMMUNOGLOBIN A
#13ANTI-IDIOTYPIC ANTIBODIES AGAINST ANTI-CD19 ANTIBODIES
#14METHODS FOR MITIGATING INTERFERENCE BY THERAPEUTIC ANTI-CD47 ANTIBODIES IN PRE-TRANSFUSION ASSAYS
#15ANTI-IDIOTYPE COMPOSITIONS AND METHODS OF USE THEREOF
#16ANTI-IDIOTYPIC ANTIBODIES TO ROR1-TARGETED BINDING DOMAINS AND RELATED COMPOSITIONS AND METHODS
#17ANTI-IDIOTYPIC ANTIBODIES AGAINST ANTI-CD79B ANTIBODIES
#18Antigen binding molecules specific for an anti-CD19 scFV
#19Monoclonal antibody against CD19 antibody and application thereof
#20ANTI-IDIOTYPE ANTIBODIES AND METHODS OF USING THE SAME
#21Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses
#22Anti-BCMA CAR antibodies, conjugates, and methods of use
#23Affinity carrier using mutant VHH antibody
#24HUMAN MONOCLONAL ANTIBODIES AGAINST CD25
#25METHODS OF TREATING NEOPLASTIC ASTROCYTOMA
#26Recombinant Cell Surface Capture Proteins
#27ANTI-IDIOTYPIC ANTIBODIES DIRECTED TO THE ANTIGEN-BINDING PORTION OF AN BCMA-BINDING MOLECULE
#28Antigen binding molecules specific for an anti-CD19 scFv
#29Human Monoclonal Antibodies Against CD20
#30ANTIBODIES AGAINST PD-L1
#31Recombinant Cell Surface Capture Proteins
#32Antigen binding molecules specific for an anti-CD19 scFv
#33METHODS OF TREATING MENINGIOMA
#34Human monoclonal antibodies against CD25
#35Method for detecting GABAA receptor autoantibodies
#36Antibodies specifically binding PD-1, TIM-3 or PD-1 and TIM-3 and their uses
#37Anti-CD154 antibodies and methods of using them
#38Cell lines expressing surface bound anti-idiotype antibodies against anti-CD22 antibodies and uses thereof
#39Human monoclonal antibodies against CD25
#40Anti-CD22 anti-idiotypic antibodies and uses thereof
#41Methods for treating muscle specific receptor kinase (MuSK) myasthenia gravis with the Ig1 domain of MuSK
#42Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
#43Anti-idiotype antibody against anti-c-MET antibody
#44Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
#45Recombinant cell surface capture proteins
#46Rapid generation of anti-idiotypic antibodies
#47Human monoclonal antibodies against CD25
#48Therapeutic using a bispecific antibody
#49Specific binding proteins and uses thereof
#50ANTI- INTEGRIN ANTIBODIES, COMPOSITIONS, METHODS AND USES
#51SPECIFIC BINDING PROTEINS AND USES THEREOF
#52HUMAN ANTI-IDIOTYPIC ANTIBODY FRAGMENTS THAT MIMIC HER-2/NEU
#53SPECIFIC BINDING PROTEINS AND USES THEREOF
#54Anti-integrin antibodies, compositions, methods and uses
#55Anti-integrin antibodies, compositions, methods and uses
#56Human monoclonal antibodies against CD25
#57PHARMACEUTICAL COMBINATIONS
#58Assay for Antibodies
#59Conjugate and its use as a standard in an immunoassay
#60Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis
#61Human anti-idiotypic antibody fragments that mimic HER-2/neu
#62Therapeutic using a bispecific antibody
#63Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
#64Anti-integrin antibodies, compositions, methods and uses
#65Assay for Antibodies
#66Polypeptides that bind an anti-tissue factor antibody and uses thereof
#67Assay for antibodies
#68Compositions and methods for the transport of biologically active agents across cellular barriers
#69Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule
#70Chimeric and humanized antibodies to α5β1 integrin that modulate angiogenesis
#71Ligands, including antibodies, showing reactivity against endocrine cells